ICICI Prudential US Bluechip Equity Fund - IDCW - Regular Plan

  • Previous Nav

  • Net Change on 23-11-2022

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - IDCW 105.03 3.13 -3.72 12.54 15.19 15.51
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 7.31 -2.46 -14.14 8.98 9.16 7.69

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - IDCW Jul 06, 2012 -3.72 12.54 15.19 2.22 2,370.11
NIPPON INDIA - US EQUITY OPPORTUNITES FUND - IDCW Option Jul 23, 2015 -16.85 7.95 12.02 2.42 524.02
Franklin Asian Equity Fund - IDCW Jan 16, 2008 -20.31 0.62 0.64 2.56 238.23
NIPPON INDIA - JAPAN EQUITY FUND - IDCW Option Aug 26, 2014 -16.25 0.75 4.00 2.44 226.66
Aditya Birla Sun Life International Equity Fund - Plan A - Regular - IDCW Nov 15, 2007 -0.86 9.10 9.96 2.51 103.85
Aditya Birla Sun Life International Equity Fund - Plan B - Regular - IDCW Oct 31, 2007 -0.60 12.87 7.72 2.55 95

Fund Holdings as on 31-October-2022

  • Wells Fargo & Co

  • Biogen Inc

  • Mercadolibre Inc

  • Microsoft Corp

  • 3M Co

  • Veeva Systems Inc

  • ETSY INC

  • Adobe Inc

  • Gilead Sciences Inc

  • Equifax Inc.

  • Zimmer Biomet Holdings Inc

  • Medtronic Plc

  • Boeing Co

  • Walt Disney

  • ServiceNow Inc.

  • Emerson Electric

  • Blackrock (US)

  • Amazon com

  • ECOLAB INC

  • Workday Inc

  • TRANSUNION

  • Lam Research Corporation

  • Tyler Technologies Inc

  • Polaris Industries Inc.

  • Salesforce.Com Inc

  • TREPS

  • Comcast Corp

  • TERADYNE INC

  • Masco Corp.

  • Intel Corp

  • Alphabet Inc

  • Facebook Inc

  • Western Union Co

  • Anheuser-Busch InBev

  • Charles Schwab Corp

  • MarketAxess Holdings Inc

  • ROCKWELL AUTOMATION INC

  • State Street Corp

  • International Flavors & Fragrances Inc

  • Nvidia Corporation

  • Fortinet INC

  • Honeywell Internation India Pvt Ltd

  • Intercontinental Exchange

  • Applied Material (US)

  • Microchip Technology Inc.

  • Allegion plc

  • KLA-Tencor corp

  • Guidewire Software Inc

  • Berkshire Hathway Inc. (US)

  • Viatris Inc

  • T. Rowe Price Associates Inc.

  • Unilever Plc

  • Taiwan Semiconductor Mfg. Co. Ltd.

  • Net Current Assets

View More
  • Miscellaneous

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹2,370.11 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.45(1.02%)yesterday to ₹44.74.

Among its top 3 holdings the fund has exposure to Wells Fargo & Co, and

The ICICI Prudential US Bluechip Equity Fund is managed by Rohan Maru and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100